Microplastics May Intensify Immune Response to Common Allergens
New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.
New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.
New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.
Read MoreHigh consumption of ultra-processed food products significantly raises the likelihood of asthma onset in school-age children, according to a longitudinal study.
Read MoreNew studies suggest that airway and breathing failures are the primary causes of death in childhood food anaphylaxis, requiring a shift in emergency management protocols.
Read MoreThe American College of Allergy, Asthma and Immunology emphasizes the link between uncontrolled allergies and asthma flares.
Read MoreA new visual Ai agent aims to reduce subjectivity and improve documentation efficiency for clinicians performing skin prick testing.
Read MoreThe European Commission authorized the EURneffy 1 mg nasal spray for pediatric patients who weigh between 15 and 30 kg and are at risk of severe allergic reactions.
Read MoreThe updated label for the Neffy 1 mg dose allows children weighing at least 33 pounds to access the needle-free treatment regardless of age.
Read MoreThe most engaging allergy/immunology social media content is often the least accurate, especially those around natural remedies and IgG testing.
Read MoreThe risk of peanut allergy was significantly reduced if the younger siblings were introduced to peanuts in their first year of life.
Read MoreA mold reduction initiative in New York City resulted in 2,798 fewer emergency department visits per year for asthma exacerbation.
Read MoreThere is no significant difference between the successful consumption of allergenic foods when using omalizumab versus multi-food oral immunotherapy.
Read MorePenicillin allergy evaluation and subsequent delabeling reduces unnecessary alternative antibiotic use and is safe for pregnant patients, according to new research presented at AAAAI 2026.
Read MoreOmalizumab reduced allergy-driving IL-4⁺ T cells and specific dendritic cell subsets, increasing patients’ tolerance to peanuts and other food allergens.
Read MoreHigh rates of comorbidity were found between specific tree nut allergies including cashew-pistachio allergies and walnut-pecan allergies.
Read MoreA non-narcotic analgesics allergy label (NNAAL) is associated with several adverse perinatal outcomes, including greater rates of NICU admission, preterm birth, and more.
Read MoreDrug allergy labels (DAL) are common and largely unevaluated in children with primary immunodeficiencies, which could lead to worse patient outcomes.
Read MoreMachine learning models showed roughly 40% improvement in diagnostic accuracy compared to standard...
Read MoreThe European Medicines Agency’s CHMP recommended expanding the marketing authorization for EURneffy to include a 1 mg dose.
Read MoreCalifornia K-12 schools are now eligible for the neffyinSchools program, providing needle-free nasal spray epinephrine at no cost for emergency use.
Read MoreA 30 mg peanut oral immunotherapy maintenance dose improved peanut tolerance to a similar extent as a higher 300 mg dose, while being associated with fewer systemic adverse events.
Read MoreThe National Medical Products Administration (NMPA) in China granted approval for neffy 2 mg (epinephrine nasal spray) for the emergency treatment of Type 1 allergic reactions in adults and children weighing 30 kg or more.
Read MoreThis fatal case of delayed anaphylaxis raises concerns about lesser-known symptoms of food allergies and a growing prevalence of lone-star tick populations.
Read MoreA Phase III NATRON trial found Fasenra (benralizumab) had benefits for patients with hypereosinophilic syndrome (HES).
Read MoreEczema is more than just a coexisting condition—it may directly influence whether children overcome food allergies.
Read More